08:40 AM EST, 11/21/2024 (MT Newswires) -- Harrow (HROW) said Thursday that a California jury ruled in favor of its subsidiary ImprimisRx in a trademark infringement against OSRX and Ocular Science.

The jury awarded $34.9 million in damages, which included $20.4 million in punitive damages and $14.5 million is actual damages, Harrow said.

OSRX did not immediately respond to a request by MT Newswires for comment.